This programme is run in conjunction with the Leukaemia Immunophenotyping (Part 1) programme.
This programme is designed to provide for a more realistic sample immunophenotyping process.
Please note that a laboratory who registers for Part One is automatically registered for Part Two and is required to complete both parts. However Part Two only registration is allowed for laboratories that do not routinely undertake immunophenotyping.
Individual registration for Part Two is also encouraged for continued professional development.
This part of the trial is designed to assess a laboratory’s ability to diagnose leukaemia using a full spectrum of laboratory tests. No samples are issued for this, the programme is totally web based. This part of the programme issues and examines a wide variety of cases. Each trial will consist of:
Participants are expected to use this information and in the diagnosis section provide a suitable diagnosis based on the World Health Organization (WHO) classification system.
This programme issues samples a minimum of 4 times per annum and a maximum of 6.
No activities in relation to this EQA programme are subcontracted.
PLEASE NOTE - A new diagnosis option has been added to the Leukaemia Diagnostic Interpretation programme.
In certain cases UK NEQAS LI appreciates that identification of the Lineage and Differentiation in a case is possible but a final diagnosis is not based on the clinical information provided.
As a result, we have included an option of 'Final diagnosis cannot be made based on the clinical information' in the diagnosis section of the result entry table
To register for this programme, please click here.